Latest European Union News

Carnegie Clean Energy has secured $2.5 million through a share placement, attracting new overseas investors to fund expansion of its CETO wave energy technology at BiMEP in Spain and commercial activities in Europe and the US.

OncoSil Medical has gained Saudi FDA approval for its OncoSil™ device, enabling full reimbursement and commercial access in Saudi Arabia, the Middle East's largest healthcare market.

Osmond Resources has confirmed a significant extension of high-grade critical mineralisation at its Orión project in Spain, with drill hole SOR-08A delivering standout assay results that expand the Southern Block resource target by over 4 square kilometres.

Karoon Energy reveals the Brazilian government has extended its 12% crude oil export tax for an additional 60 days. The company continues legal efforts to contest the tax while leveraging trade agreements to mitigate its impact.

Euro Manganese has restructured its $23.5 million convertible loan with Orion into a royalty on its Chvaletice Manganese Project, enhancing financial flexibility and streamlining its capital structure ahead of project development.

European Metals Holdings has revealed preliminary testwork results indicating a potential switch to a tunnel kiln for its Cinovec Lithium Project, promising substantial capital and operating cost savings alongside a reduced carbon footprint.

ClearVue Technologies has earned three international certifications for its Gen 3 Vision Glass, confirming its photovoltaic performance, safety, and durability across multiple product variants.

Kingston Resources has launched a fully underwritten $8.47 million rights issue priced at 3.5 cents per share to support a major drilling campaign and plant expansion at its Mineral Hill project.

Osmond Resources is advancing its Orión EU Critical Minerals Project with imminent assay results, upcoming resource estimates, and a secondary listing on the Madrid Stock Exchange, aiming to become the EU's first producer of rare earth-bearing minerals.

OncoSil Medical secures a spot in the PALACROS consortium, advancing its OncoSil™ device through a cost-efficient Phase II trial targeting unresectable locally advanced pancreatic cancer.

Euro Manganese has filed comprehensive NI 43-101 and JORC reports for its Chvaletice Manganese Project, confirming robust economics with a base case post-tax NPV of US$492 million and an upside scenario pushing NPV to US$798 million, driven by higher manganese prices.

4DMedical has cleared a major regulatory hurdle with the Therapeutic Goods Administration approving its CT:VQ™ lung imaging software, paving the way for commercial use across Australia and strengthening its global footprint.